Usefulness of homocysteine as a cancer marker: Total thiol compounds and folate levels in untreated lung cancer patients

Anticancer Research

Volumn 27, Issue 2, 2007, Pages 1185-1189

  Özkan, Yeşim ^a   Yardim Akaydin, Sevgi ^a   Firat, Hikmet ^b   Çalişkan Can, Emel ^a   Ardiç, Sadik ^b   Şimşek, Bolkan ^a  

^a GAZI UNIVERSITY   (Turkey)

^b Social Ins Hospital of Children   (Turkey)

Author keywords

Cysteine; Folate; Glutathione; Homocysteine; Lung cancer; Tumor marker

Indexed keywords

CYSTEINE; FOLIC ACID; GLUTATHIONE; HOMOCYSTEINE; THIOL DERIVATIVE; TUMOR MARKER;

ADULT; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FLUOROMETRY; FOLIC ACID; HOMOCYSTEINE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; SULFHYDRYL COMPOUNDS; TUMOR MARKERS, BIOLOGICAL;

EID: 34247149967     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Cesari M, Rossi GP, Sticchi D and Pessina AC: Is homocysteine important as risk factor for coronary heart disease? Nutr Metab Cardiovas 15: 140-147, 2005.
2. Perna AF, Satta E, Lombardi C, Acanfora F, Ingrosso D and Santo NG: Hyperhomocysteinemia and the cardiovascular disease of uremia. Nutr Res 24: 839-849, 2004.
3. Cotter AM, Molloy AM, Scott JM and Daly SF: Elevated plasma homocysteine in early pregnancy: a risk factor for the development of nonsevere preeclampsia. Am J Obstet Gynecol 189: 391-394, 2003.
4. Mattson MP and Shea TB: Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders.Trends Neurosci 26: 137-146, 2003.
5. Andria G, Scala I and Sebastio G: Health implication of homocysteine and folates: possible preventive measures. Nutr Metab Cardiovas 15: 1587-1593, 2005.
6. Molloy AM: Folate and homocysteine interrelationship including genetics of the relevant enzymes. Curr Opin Lipidol 15: 49-57, 2004.
7. Cellarier E, Durando X, Vasson MP, Farges MC, Demiden A, Maurizis JC, Madelmont JC and Chollet P: Methionine dependency and cancer treatment. Cancer Treat Rev 29: 489-499, 2003.
8. Lucock M: Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 71: 121-138, 2000.
9. Corona G, Toffoli G, Fabris M, Viel A, Zarrelli A, Donada C and Boiocchi M: Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells. Eur J Cancer 33: 1284-1290, 1997.
10. Sun CF, Haven TR, Wu TL, Tsao KC and Wu JT: Serum total homocysteine increases with the rapid proliferation rate of tumor cells and decline upon cell death: a potential new tumor marker. Clin Chim Acta 321: 55-62, 2002.
11. Kato I, Dnistrian AM, Schwartz M, Toniolo P, Koenig K, Shore RE, Akhmedkhanov A, Zeleniuch-Jacquotte A and Riboli E: Serum folate, homocysteine and colerectal cancer risk in women: nested case-control study. Br J Cancer 79: 1917-1922, 1999.
12. Almadori G, Bussi F, Galli J, Cadoni G, Zappacosta B, Persichilli S, Minucci A and Giardina B: Serum folate and homocysteine levels in head and neck squamous cell carcinoma. Cancer 94: 1006-1011, 2002.
13. 12 in head and neck squamous cell carcinoma and in laryngeal leukoplakia. Cancer 103: 284-292, 2005.
14. Ueland PM and Refsum H: Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med 114: 473-501, 1989.
15. Sobin LH and Wittekind C: TNM Classification of Malignant Tumours. 6th Ed. International Union Against Cancer. New York, Wiley-Liss. 2002.
16. Vester B and Rasmussen K: High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem 29: 549-54, 1991.
17. Krijt J, Vackova M and Kozich V: Measurement of homocysteine and other aminothiols in plasma: advantages of using tris(2-carboxyethyl)phosphine as reductant compared with tri-n-buthylphosphine. Clin Chem 47: 1821-1828, 2001.
18. Digel W and Lübbert M: DNA methylation disturbances as novel therapeutic target in lung cancer: preclinical and clinical results. Crit Rev Oncol Hemat 55: 1-11, 2005.
19. Warnecke PM and Bestor TH: Cytosine methylation and human cancer. Curr Opin Oncol 12: 68-73, 2000.
20. Shen M, Rothman N, Berndt SI, He XZ, Yeager M, Welch R, Chanock S, Caporaso N and Lan Q: Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, China. Lung Cancer-J IASLC 49: 299-309, 2005.
21. Bandera EV, Freudenheim JL, Marshall JR, Zielezny M, Priore RL, Brasure J, Baptiste M and Graham S: Diet and alcohol consumption and lung cancer risk in the New York State Cohort (United States). Cancer Cause Control 8: 828-840, 1997.
22. Choi SW and Mason JB: Folate and carcinogenesis: an integrated scheme. J Nutr 130: 129-132, 2000.
23. Kim YI: Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 10: 66-88, 1999.
24. Giovannuci E: Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 31: 925-943, 2002.
25. Beilby J, Ingram D, Hähnel R and Rossi E: Reduced breast cancer risk with increasing serum folate in a case-control study of the C677T genotype of the methylenetetrahydrofolate reductase gene. Eur J Cancer 40: 1250-1254, 2004.
26. Shen H, Wei O, Pillow PC, Amos CI, Hong WK and Spitz MR: Dietary folate intake and lung cancer risk in former smokers: a case-control analysis. Cancer Epidem Biomar 12: 980-986, 2003.
27. Lascalzo J: The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 98: 5-7, 1996.
28. Muniz P, Saez P, Idare A, Vina J, Oliva MR and Saer GT: Differences between cysteine and homocysteine in the induction of deoxyribose degradation and DNA damage. Free Rad Biol Med 30: 354-362, 2001.
29. Saydam N, Kirb A, Demir KÖ, Hazan E, Oto Ö, Saydam O and Güner G: Determination of glutathione, glutathione reductase, glutathione peroxidase and glutathione S-transferase levels in human lung cancer tissues. Cancer Lett 119: 13-19, 1997.
30. Kaynar H, Meral M, Turhan H, Keleş M, Çelik G and Akçay F: Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. Cancer Lett 227: 133-139, 2005.
31. Jakubowski H: Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. J Nutr 130: 377-381, 2000.